James C. Clemmer
President and CEO at AngioDynamics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: AngioDynamics Inc., 3 years.
AngioDynamics Inc.
Director · President and CEO
Chief executive roles
AngioDynamics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 22, 2026 | AngioDynamics Inc. | Option exercise | +52,358 | — | — |
| Jul 22, 2026 | AngioDynamics Inc. | Shares withheld for tax | −26,728 | $13.82 | $369,381 |
| Jul 20, 2026 | AngioDynamics Inc. | Shares withheld for tax | −4,223 | $13.71 | $57,897 |
| Jul 19, 2026 | AngioDynamics Inc. | Shares withheld for tax | −11,764 | $13.51 | $158,932 |
| Jul 19, 2026 | AngioDynamics Inc. | Shares withheld for tax | −487 | $13.51 | $6,579 |
| Jul 17, 2026 | AngioDynamics Inc. | Shares withheld for tax | −10,649 | $13.51 | $143,868 |
| Jul 16, 2026 | AngioDynamics Inc. | Shares withheld for tax | −18,588 | $14.14 | $262,834 |
| Oct 9, 2025 | AngioDynamics Inc. | Open-market purchase | +10,000 | $11.15 | $111,500 |
| Jul 20, 2025 | AngioDynamics Inc. | Shares withheld for tax | −2,982 | $8.69 | $25,914 |
| Jul 20, 2025 | AngioDynamics Inc. | Shares withheld for tax | −3,673 | $8.99 | $33,020 |
| Jul 19, 2025 | AngioDynamics Inc. | Shares withheld for tax | −344 | $8.69 | $2,989 |
| Jul 19, 2025 | AngioDynamics Inc. | Shares withheld for tax | −8,307 | $8.69 | $72,188 |
| Jul 16, 2025 | AngioDynamics Inc. | Grant or award | +206,253 | — | — |
| Oct 7, 2024 | AngioDynamics Inc. | Open-market purchase | +20,000 | $6.03 | $120,600 |
| Jul 21, 2024 | AngioDynamics Inc. | Shares withheld for tax | −3,372 | $7.13 | $24,042 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.